Company Description

Qurgen has developed innovative therapies for cancer, heart failure, diabetes, anti-aging and eye disease by in vivo reprogramming damaged, diseased, or degenerated tissue cells into stem cells that quickly differentiate into younger healthy tissue cells using our patented and safe protein-induced in vivo disease tissue reprogramming technology platforms with different transcription factor protein drugs.